These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38150499)

  • 1. B56δ long-disordered arms form a dynamic PP2A regulation interface coupled with global allostery and Jordan's syndrome mutations.
    Wu CG; Balakrishnan VK; Merrill RA; Parihar PS; Konovolov K; Chen YC; Xu Z; Wei H; Sundaresan R; Cui Q; Wadzinski BE; Swingle MR; Musiyenko A; Chung WK; Honkanen RE; Suzuki A; Huang X; Strack S; Xing Y
    Proc Natl Acad Sci U S A; 2024 Jan; 121(1):e2310727120. PubMed ID: 38150499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended regulation interface coupled to the allosteric network and disease mutations in the PP2A-B56δ holoenzyme.
    Wu CG; Balakrishnan VK; Parihar PS; Konovolov K; Chen YC; Merrill RA; Wei H; Carragher B; Sundaresan R; Cui Q; Wadzinski BE; Swingle MR; Musiyenko A; Honkanen R; Chung WK; Suzuki A; Strack S; Huang X; Xing Y
    bioRxiv; 2023 Apr; ():. PubMed ID: 37066309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coupling to short linear motifs creates versatile PME-1 activities in PP2A holoenzyme demethylation and inhibition.
    Li Y; Balakrishnan VK; Rowse M; Wu CG; Bravos AP; Yadav VK; Ivarsson Y; Strack S; Novikova IV; Xing Y
    Elife; 2022 Aug; 11():. PubMed ID: 35924897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantum-based modeling implies that bidentate Arg
    Salter EA; Wierzbicki A; Honkanen RE; Swingle MR
    Front Cell Dev Biol; 2023; 11():1141804. PubMed ID: 37377738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of liprin-α1 phosphorylation in its liquid-liquid phase separation: regulation by PPP2R5D/PP2A holoenzyme.
    Mayer A; Derua R; Spahn E; Verbinnen I; Zhang Y; Wadzinski B; Swingle MR; Honkanen R; Janssens V; Xia H
    bioRxiv; 2024 Jun; ():. PubMed ID: 38948786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPM1G forms a PPP-type phosphatase holoenzyme with B56δ that maintains adherens junction integrity.
    Kumar P; Tathe P; Chaudhary N; Maddika S
    EMBO Rep; 2019 Oct; 20(10):e46965. PubMed ID: 31432583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability.
    Houge G; Haesen D; Vissers LE; Mehta S; Parker MJ; Wright M; Vogt J; McKee S; Tolmie JL; Cordeiro N; Kleefstra T; Willemsen MH; Reijnders MR; Berland S; Hayman E; Lahat E; Brilstra EH; van Gassen KL; Zonneveld-Huijssoon E; de Bie CI; Hoischen A; Eichler EE; Holdhus R; Steen VM; Døskeland SO; Hurles ME; FitzPatrick DR; Janssens V
    J Clin Invest; 2015 Aug; 125(8):3051-62. PubMed ID: 26168268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative proteomics and phosphoproteomics of PP2A-PPP2R5D variants reveal deregulation of RPS6 phosphorylation via converging signaling cascades.
    Smolen KA; Papke CM; Swingle MR; Musiyenko A; Li C; Salter EA; Camp AD; Honkanen RE; Kettenbach AN
    J Biol Chem; 2023 Sep; 299(9):105154. PubMed ID: 37572851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Adrenergic regulation of cardiac type 2A protein phosphatase through phosphorylation of regulatory subunit B56δ at S573.
    Ranieri A; Kemp E; Burgoyne JR; Avkiran M
    J Mol Cell Cardiol; 2018 Feb; 115():20-31. PubMed ID: 29294329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPP2R5D-Related Intellectual Disability and Neurodevelopmental Delay: A Review of the Current Understanding of the Genetics and Biochemical Basis of the Disorder.
    Biswas D; Cary W; Nolta JA
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32074998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease mutations and phosphorylation alter the allosteric pathways involved in autoinhibition of protein phosphatase 2A.
    Konovalov KA; Wu CG; Qiu Y; Balakrishnan VK; Parihar PS; O'Connor MS; Xing Y; Huang X
    J Chem Phys; 2023 Jun; 158(21):. PubMed ID: 37260014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56delta subunit.
    Ahn JH; McAvoy T; Rakhilin SV; Nishi A; Greengard P; Nairn AC
    Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2979-84. PubMed ID: 17301223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cAMP-stimulated protein phosphatase 2A activity associated with muscle A kinase-anchoring protein (mAKAP) signaling complexes inhibits the phosphorylation and activity of the cAMP-specific phosphodiesterase PDE4D3.
    Dodge-Kafka KL; Bauman A; Mayer N; Henson E; Heredia L; Ahn J; McAvoy T; Nairn AC; Kapiloff MS
    J Biol Chem; 2010 Apr; 285(15):11078-86. PubMed ID: 20106966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of protein phosphatase 2A (PP2A) complexity reveals cellular functions and dephosphorylation motifs of the PP2A/B'δ holoenzyme.
    Jong CJ; Merrill RA; Wilkerson EM; Herring LE; Graves LM; Strack S
    J Biol Chem; 2020 Apr; 295(17):5654-5668. PubMed ID: 32156701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ser70 phosphorylation of Bcl-2 by selective tyrosine nitration of PP2A-B56δ stabilizes its antiapoptotic activity.
    Low IC; Loh T; Huang Y; Virshup DM; Pervaiz S
    Blood; 2014 Oct; 124(14):2223-34. PubMed ID: 25082878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth.
    Papke CM; Smolen KA; Swingle MR; Cressey L; Heng RA; Toporsian M; Deng L; Hagen J; Shen Y; Chung WK; Kettenbach AN; Honkanen RE
    J Biol Chem; 2021; 296():100313. PubMed ID: 33482199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation on the PPP2R5D B regulatory subunit modulates the biochemical properties of protein phosphatase 2A.
    Yu UY; Ahn JH
    BMB Rep; 2010 Apr; 43(4):263-7. PubMed ID: 20423611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of PPP2 syndrome type R5D (Jordan's syndrome) to support standardization of care.
    Levine AD; Chung WK
    Cold Spring Harb Mol Case Stud; 2023 Jun; 9(3):. PubMed ID: 37339871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt.
    Kuo YC; Huang KY; Yang CH; Yang YS; Lee WY; Chiang CW
    J Biol Chem; 2008 Jan; 283(4):1882-92. PubMed ID: 18042541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De Novo Mutations Affecting the Catalytic Cα Subunit of PP2A, PPP2CA, Cause Syndromic Intellectual Disability Resembling Other PP2A-Related Neurodevelopmental Disorders.
    Reynhout S; Jansen S; Haesen D; van Belle S; de Munnik SA; Bongers EMHF; Schieving JH; Marcelis C; Amiel J; Rio M; Mclaughlin H; Ladda R; Sell S; Kriek M; Peeters-Scholte CMPCD; Terhal PA; van Gassen KL; Verbeek N; Henry S; Scott Schwoerer J; Malik S; Revencu N; Ferreira CR; Macnamara E; Braakman HMH; Brimble E; Ruzhnikov MRZ; Wagner M; Harrer P; Wieczorek D; Kuechler A; Tziperman B; Barel O; de Vries BBA; Gordon CT; Janssens V; Vissers LELM
    Am J Hum Genet; 2019 Jan; 104(1):139-156. PubMed ID: 30595372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.